Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Gilbert

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
Urologic Oncology|November 21, 2009
Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United StatesScott M Gilbert, Yong-Fang Kuo, Vahakn B Shahinian
Current Urology Reports|June 27, 2002
Linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in the African-American populationScott M Gilbert, Mitchell C Benson, James M McKiernan
Nature Reviews. Urology|July 2, 2014
Sexual dysfunction after cystectomy and urinary diversionRishi A Modh, John P Mulhall, Scott M Gilbert
The New England Journal of Medicine|November 5, 2010
Reimbursement policy and androgen-deprivation therapy for prostate cancerVahakn B Shahinian, Yong-Fang Kuo, Scott M Gilbert
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2016
Geographical Factors Associated With Health Disparities in Prostate CancerScott M Gilbert, Julio M Pow-Sang, Hong Xiao
Urologic Oncology|July 6, 2011
Advanced topics in evidence-based urologic oncology: economic analysisBruce Vogel, Scott M Gilbert, Jill Boylston Herndon, et al.
European Urology|May 7, 2019
Reply to Yubo Yang, Xin Wei, and Ping Han's Letter to the Editor re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol 2019;76:4-6Roger Li, Philippe E Spiess, Scott M Gilbert, et al.
European Urology|March 6, 2019
Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder CancerRoger Li, Philippe E Spiess, Scott M Gilbert, et al.
Urology|March 23, 2005
Evidence suggesting PSA cutpoint of 2.5 ng/mL for prompting prostate biopsy: review of 36,316 biopsiesScott M Gilbert, Christina B Cavallo, Hillel Kahane, et al.
The Journal of Urology|March 19, 2013
Downstream complications following urinary diversionScott M Gilbert, Julie Lai, Christopher S Saigal, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Urologic Oncology|November 21, 2009
Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United StatesScott M Gilbert, Yong-Fang Kuo, Vahakn B Shahinian
Current Urology Reports|June 27, 2002
Linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in the African-American populationScott M Gilbert, Mitchell C Benson, James M McKiernan
Nature Reviews. Urology|July 2, 2014
Sexual dysfunction after cystectomy and urinary diversionRishi A Modh, John P Mulhall, Scott M Gilbert
The New England Journal of Medicine|November 5, 2010
Reimbursement policy and androgen-deprivation therapy for prostate cancerVahakn B Shahinian, Yong-Fang Kuo, Scott M Gilbert
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2016
Geographical Factors Associated With Health Disparities in Prostate CancerScott M Gilbert, Julio M Pow-Sang, Hong Xiao
Urologic Oncology|July 6, 2011
Advanced topics in evidence-based urologic oncology: economic analysisBruce Vogel, Scott M Gilbert, Jill Boylston Herndon, et al.
European Urology|May 7, 2019
Reply to Yubo Yang, Xin Wei, and Ping Han's Letter to the Editor re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol 2019;76:4-6Roger Li, Philippe E Spiess, Scott M Gilbert, et al.
European Urology|March 6, 2019
Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder CancerRoger Li, Philippe E Spiess, Scott M Gilbert, et al.
Urology|March 23, 2005
Evidence suggesting PSA cutpoint of 2.5 ng/mL for prompting prostate biopsy: review of 36,316 biopsiesScott M Gilbert, Christina B Cavallo, Hillel Kahane, et al.
The Journal of Urology|March 19, 2013
Downstream complications following urinary diversionScott M Gilbert, Julie Lai, Christopher S Saigal, et al.
Pageof 17